Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Bridging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of FB2001 in Healthy Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 16 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bofutrelvir (Primary)
Indications COVID 2019 infections
Focus Adverse reactions; Pharmacokinetics
Sponsors Frontier Biotechnologies

Most Recent Events

08 Aug 2022 According to a Frontier Biotechnologies media release, data from this trial were presented at the poster session of the 11th International Conference on Emerging Infectious Diseases (ICEID) 2022.
08 Aug 2022 Positive results published in the Frontier Biotechnologies Media Release.
30 Jun 2022 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com